The population density of Washington County, MD was 327 in 2018. The population density of Lebanon County, PA was 383 in 2018.
Population Density
Population Density is computed by dividing the total population by Land Area Per Square Mile.
Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API -
Geographic and Population Datasets Involving Lebanon County, PA or Washington County, MD
- API
WAOFM - Census - Population and Housing, 2000 and 2010
data.wa.gov | Last Updated 2021-09-01T17:20:31.000ZPopulation and housing information extracted from decennial census Public Law 94-171 redistricting summary files for Washington state for years 2000 and 2010.
- API
WAOFM - Census - Population Density by County by Decade, 1900 to 2020
data.wa.gov | Last Updated 2023-07-06T16:48:57.000ZWashington state population density by county by decade 1900 to 2020.
- API
Maryland Resident Population Per Square Mile: 2010-2020
opendata.maryland.gov | Last Updated 2024-03-11T18:51:03.000ZResident population density for Maryland and Jurisdictions per square mile from 2010 to 2020. Source: U.S. Bureau of Census
- API
MUNICIPAL_BOUNDARY
data.pa.gov | Last Updated 2024-07-25T06:08:41.000Z - API
Pennsylvania Professional Licensee Data County State
data.pa.gov | Last Updated 2024-03-14T13:31:13.000ZThis dataset contains counts of professional licensees per each licensed occupation and is broken down by County of licensee. *Appearances of non-Pennsylvania counties in the data are due to practitioners that are either licensed to practice in Pennsylvania but live out of state or own a facility in Pennsylvania but live out of state. **Appearances of null values in the data are due to the county field being an optional field for a license application and the county does not auto populate based on the address at this point in time.
- API
Dispensation Data without Buprenorphine Quarter 3 2016 - Current Quarterly County Health
data.pa.gov | Last Updated 2024-08-12T15:42:38.000ZView quarterly trends in opioid dispensation data for all Schedule II-V opioids. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx More information from U.S. Department of Justice https://www.deadiversion.usdoj.gov/schedules/ Schedule I Controlled Substances Substances in this schedule have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-methylenedioxymethamphetamine ("Ecstasy"). Schedule II/IIN Controlled Substances (2/2N) Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence. Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone (Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl (Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine, and hydrocodone. Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®), methamphetamine (Desoxyn®), and methylphenidate (Ritalin®). Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital. Schedule III/IIIN Controlled Substances (3/3N) Substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. Examples of Schedule III narcotics include: products containing not more than 90 milligrams of codeine per dosage unit (Tylenol with Codeine®), and buprenorphine (Suboxone®). Examples of Schedule IIIN non-narcotics include: benzphetamine (Didrex®), phendimetrazine, ketamine, and anabolic steroids such as Depo®-Testosterone. Schedule IV Controlled Substances Substances in this schedule have a low potential for abuse relative to substances in Schedule III. Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol (Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®), lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam (Halcion®). Schedule V Controlled Substances Substances in this schedule have a low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics. Examples of Schedule V substances include: cough preparations containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams (Robitussin AC®, Phenergan with Codeine®), and ezogabine.
- API
Dangerous Dogs 1996-Current County Agriculture
data.pa.gov | Last Updated 2020-02-27T14:35:08.000ZHistorical results of Dangerous Dogs in Pennsylvania. A dangerous dog is one that has: (1) Inflicted severe injury on a human being without provocation on public or private property. (2) Killed or inflicted severe injury on a domestic animal, dog or cat without provocation while off the owner’s property. (3) Attacked a human being without provocation. (4) Been used in the commission of a crime. And the dog has either or both of the following: (1) A history of attacking human beings and/or domestic animals, dogs or cats without provocation. (2) A propensity to attack human beings and/or domestic animals, dogs or cats without provocation. *A propensity to attack may be proven by a single incident. Severe injury is defined as, [3 P.S. § 459-102] “Any physical injury that results in broken bones or disfiguring lacerations requiring multiple sutures or cosmetic surgery.” More information can be found here - https://www.agriculture.pa.gov/Animals/DogLaw/Dangerous%20Dogs/Pages/default.aspx More information on Chapter 27 Regulations - https://www.agriculture.pa.gov/Animals/DogLaw/Dangerous%20Dogs/Documents/Chapter%2027%20Dangerous%20Dogs.pdf PDF's for Chapter 27 and Pennsylvania Dog Laws are attached to the metadata
- API
WAOFM - April 1 - Population Density by County, 2000 to Present
data.wa.gov | Last Updated 2024-07-11T21:24:42.000ZIntercensal and postcensal estimates of population density by county 2000 to present.
- API
Buprenorphine Dispensation Data Quarter 3 2016 - Current Quarterly Statewide Health
data.pa.gov | Last Updated 2024-08-12T15:42:31.000ZView quarterly trends in buprenorphine dispensation data. Please note that buprenorphine data received by the PDMP is restricted to prescriptions filled by pharmacies. The PDMP does not collect information on the reason a controlled substance is prescribed, nor does it collect data from substance abuse treatment facilities or dispensing prescribers providing buprenorphine for substance abuse treatment. Buprenorphine is sometimes prescribed off-label for pain. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx
- API
Park and Ride Locations Current Transportation
data.pa.gov | Last Updated 2024-09-15T05:03:27.000ZPennDOT Official Park and Ride information that is currently available. This is not all inclusive.